Prescribing guidance

This guidance focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and incorporates a risk/benefit assessment tool, and a one-page summary for Welsh healthcare practitioners choosing a direct oral anticoagulant in this patient population.

This guidance has been developed to help support healthcare professionals in the prescribing of SGLT-2 inhibitors in patients with type 2 diabetes mellitus and cardiovascular disease.

This educational pack aims to support the appropriate prescribing of hypnotics and anxiolytics across Wales by providing key health professionals with a practical approach for the initiation and review of hypnotic and anxiolytic prescribing.

The Welsh National Standards for Medication Review have been developed to provide a structured approach to medication review and are benchmarks for quality, with the aim of optimising patient safety and prescribing practice.

This document aims to inform and guide healthcare staff in NHS Wales about how to start nicotine replacement therapy (NRT) to manage nicotine withdrawal in adults who smoke and are admitted to hospital (secondary care).

This document updates the principles of best practice for shared care prescribing agreements.

This short ‘Best Practice Reminder’ document has been developed to inform primary care prescribers about avoiding the prescribing of nitrofurantoin in patients with suspected pyelonephritis, the rationale behind this and what can be prescribed in its place.

The aim of the counselling checklist is to assist healthcare professionals, working in community pharmacies, primary care and secondary care, in the essential counselling of patients on the safe and effective use of opioid patches.

This guidance is intended to provide managers, responsible individuals, registered nurses and care support workers in Welsh organisations with information on how and when a registered nurse may delegate the task of medicines support to a care support worker, and the necessary education and training standards, and policies and procedures that are required to facilitate this.

The All Wales Guide to Prescribing Gluten-free Products aims to support general practitioners and other healthcare professionals in the management of patients with coeliac disease, and aid the decision-making process in relation to prescribing Advisory Committee on Borderline Substances (ACBS)-approved gluten-free foods.

This document aims to highlight and help address the patient safety issues associated with the long-term use of proton pump inhibitors (PPIs) in adults.

This guide supports the appropriate prescribing and supply of smoking cessation pharmacotherapy in NHS Wales for smokers who are motivated to quit.

This policy document has been developed to provide healthcare professionals with information to promote the safe and timely completion of medicines reconciliation and provides guidance on completing the process.

This CKD medicines management resource includes supporting information for primary care teams around clinical issues, signposts to further useful resources and contains an educational slide set.

This guidance aims to provide healthcare professionals with information to better inform patients on how to manage dry eye syndrome using good eyelid hygiene.

The purpose of this guidance is to raise awareness of the recommendations on routine vitamin supplementation for babies, children, and pregnant and breastfeeding women, including vitamin D.

This document aims to ensure that all patients receive appropriate anticoagulation in a timely manner and to address prescribers’ concerns relating to the safe prescribing of LMWH.

Primary and secondary care clinicians have recognised that it would be beneficial to review all patients taking amiodarone in Wales to establish the need for ongoing treatment. The enclosed documentation has been developed to assist this process.